Company profile
SKINVISIBLE, INC. CIK 1085277
Ticker
SKVI (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Las Vegas, NV 89120
Fiscal year end
2025 (FY)
Key Financials
Revenue
$20.0K
Net income
-$1.06M
Total assets
$127.6K
Total liabilities
$10.39M
Stockholders' equity
-$10.26M
Cash & equivalents
$2.6K
Operating income
-$496.3K
Operating cash flow
-$38.4K
Capital expenditures
$4.1K
Fiscal year 2025, via 10-K filed 2026-03-31. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-2,481.6%
Net margin
-5,320.2%
Free cash flow
-$42.5K
Free cash flow margin
-212.5%
Liabilities / assets
8,145.0%
Equity / assets
-8,045.0%
CapEx / revenue
20.4%
Operating cash flow / net income
0.04×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
$20.0K
-$1.06M
$127.6K
$10.39M
-$10.26M
2024
$20.0K
-$565.7K
$158.2K
$9.38M
-$9.22M
2023
$20.0K
-$2.38M
$162.9K
$9.19M
-$9.02M
2022
$279.3K
-$1.22M
$246.8K
$6.89M
-$6.64M
2021
$663.4K
-$1.07M
$227.3K
$5.64M
-$5.42M
Company Details
SIC code
2834
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-13
Financials filed via
Form 10-K
filed 2026-03-31
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Las Vegas, NV 89120
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:38 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.